Synopsis of recent research by authors named "Mark N Prichard"
- Mark N Prichard's recent research focuses primarily on the development of antiviral therapeutics targeting various DNA viruses, including cytomegalovirus (CMV), herpes simplex virus (HSV), and hepatitis B virus (HBV), aiming to overcome challenges related to drug resistance and toxicity.
- His investigations include analyzing mechanisms of viral transmission and diversity, as seen in studies on neonatal herpes simplex virus transmission and the mutations in viral genes that influence infection outcomes.
- Prichard's findings highlight the potential of novel compounds, such as NPP-669 and N-arylpyrimidinamine (NAPA), showing promise as early-stage inhibitors against CMV, as well as the need for standardized evaluation methods for antiviral activities across different laboratory settings.
